UZ Leuven
Leuven, 3000, Belgium
NCT Number: NCT04252027
This prospective study will research the exposure and its variability to fluconazole after longitudinal administration in critically ill patients
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Leuven, 3000, Belgium
An open label, monocenter pharmacokinetic study will be carried out in critically ill patients, admitted at the University Hospitals Leuven, receiving multiple dose treatment with fluconazole.
The exposure to fluconazole in the ICU cohort over multiple days of treatment will be documented. Moreover, variability and the correlating covariates that can influence the fluconazole concentration, will be determined.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Plasma and urine sample collection
Time frame: On the day of sampling
To document the trough levels (Cmin) of fluconazole in an ICU cohort over multiple days of treatment
Time frame: June 2020
Determine if the Cmin target levels are attained.
Time frame: June 2020
To determine the intra-and intersubject variability of the fluconazole trough levels
Time frame: June 2020
Determine possible covariates that might explain the fluconazole variability
Universitaire Ziekenhuizen KU Leuven
Other
Therapeutic Drug Monitoring of Fluconazole in Critically Ill Patients: a Longitudinal Follow-up of Trough Levels
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05464979
Critically Ill Patients
Wuhan, Hubei, China
View Trial DetailsNCT07025941
Acute Kidney Injury, Acute Kidney Injury (AKI)
Taizhou, Jiangsu, China
View Trial DetailsNCT06580704
Anesthesia, Critically Ill Patients
Tanta, El-Gharbia, Egypt
View Trial DetailsNCT05790915
Critically Ill Patients
São Luís, Maranhão, Brazil
View Trial Details